GlaxoSmithKline Pharmaceuticals informs about issue of duplicate share certificates

24 Apr 2024 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder, as details enclosed. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2080.15 -13.70 (-0.65%)
06-May-2024 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1524.20
Dr. Reddys Lab 6282.35
Cipla 1426.05
Zydus Lifesciences 1005.90
Lupin 1653.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.